Untreated Malignant Lymphomas Using Page 1 Evaluation of Therapy Response in Children
with Untreated Malignant Lymphomas Using Technetium—99m—Sestamibi L. Ozlem Kapucu …

Background: The rationale of the present study is based on the property of technetium-
SESTAMIBI to enter malignant and other highly metabolic cells, and then to be pumped out …

with octreotide. Finally. although metabolic therapy using Page 1 sensitivity of lymphoma lesion
detection as opposed to the constantly good results in GEP tumors. Also, SRI may not be …

Somatostatin receptor scintigraphy (SRS) is useful in diagnosing tumours with increased
expression of somatostatin receptors. Lymphoma cells are known to express somatostatin …

The purpose of this study was to predict chemotherapy response using technetium‐99m
methoxyisobutylisonitrile (Tc‐MIBI) scintigraphy in untreated adult malignant lymphomas …

Technetium-99m sestamibi scintimammography has been used primarily in the diagnosis of
breast cancer. It has also been suggested that this technique could be used to monitor …

Hexakis (2-methoxyisobutylisonitrile) technetium-99m (99mTc-SestaMIBI) is a
radiopharmaceutical used in nuclear medicine for myocardial perfusion imaging. In the …

Our nuclear pharmacy has reported that a failed radiochemical purity (RCP)(ie, RCP< 90%)
of 99mTc-sestamibi may be associated with the use of a first elution at later stages from a …

Our nuclear pharmacy noted that 99mTc-sestamibi kits sometimes failed radiochemical
purity (RCP) testing (ie, RCP< 90%). All failed kits had been prepared with eluate from a …

Studies are currently underway to determine if simi lar results are observed with tumors
other than pediatric astrocytomas as well as to elucidate the mechanism of uptake of …